First, the dude is short. He doesn't mention anything about the strong peer reviewed science. He doesn't mention that Dr. Kim the CEO has 99.9% of his personal net worth invested in the company. He doesn't mention the brainiacs on the scientific advisory board who say the possibilities for INO are limitless. In fact, he doesn't mention any real reason to be short the stock other than he stands to lose a bundle if it goes up. So, if he is short...I am long and strong!
Sentiment: Strong Buy
yes, but he does mention INO paying a PR firm......LOL!....Does this mean its doomed for failure and its a scam? Is Roche in on it as well as the yet to be named biotech investors at $2.90 a share? Does he mention if anything the PR firm has stated is not factual?? ......oh well....sucks to be him.... : D
SA was discredited a not long ago for publishing questionable articles designed to influence stock. I feel for the people reading them who rely on it as good DD. I don't care for reading anything they publish, or Motley, either. It's all opinion from people with agendas.